Fig. 1From: Octamer-binding transcription factor 4-positive circulating tumor cell predicts worse treatment response and survival in advanced cholangiocarcinoma patients who receive immune checkpoint inhibitors treatmentThe proportions of advanced CCA patients with none CTC, OCT4−CTC, and OCT4+CTCBack to article page